GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | February 19, 2025 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
2XEG | Q04609 | Human glutamate carboxypeptidase II in complex with Antibody- Recruiting Molecule ARM-P4 | |
2XEF | Q04609 | Human glutamate carboxypeptidase II in complex with Antibody- Recruiting Molecule ARM-P8 | |
3CEJ | P06737 | Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE2865 | Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE2865 |
3CEM | P06737 | Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE9423 | Glycogen phosphorylase (E.C.2.4.1.1) |
8CVX | P13807 | Human glycogenin-1 and glycogen synthase-1 complex in the presence of glucose-6-phosphate | |
8CVX | P46976 | Human glycogenin-1 and glycogen synthase-1 complex in the presence of glucose-6-phosphate | |
5ZHO | Q82040 | Human group C rotavirus VP8*s recognize type A histo-blood group antigens as ligands | |
4X0L | P69905 | Human haptoglobin-haemoglobin complex | |
4X0L | P68871 | Human haptoglobin-haemoglobin complex | |
4X0L | P00738 | Human haptoglobin-haemoglobin complex | |
7ZAY | Q16394 | Human heparan sulfate polymerase complex EXT1-EXT2 | |
7ZAY | Q93063 | Human heparan sulfate polymerase complex EXT1-EXT2 | |
8CQI | Q9Y251 | Human heparanase in complex with inhibitor R3794 | |
7B7N | P29317 | Human herpesvirus-8 gH/gL in complex with EphA2 | |
7B7N | Q98142 | Human herpesvirus-8 gH/gL in complex with EphA2 | |
7B7N | Q76RG7 | Human herpesvirus-8 gH/gL in complex with EphA2 | |
8ZQO | Q9GZV3 | Human high-affinity choline transporter CHT1 bound to HC-3 under NaCl condition, with sodium and chloride ions coordinated. | |
8ZQP | Q9GZV3 | Human high-affinity choline transporter CHT1 bound to ML352 under NaCl condition, with sodium ion coordinated. | |
8ZQQ | Q9GZV3 | Human high-affinity choline transporter CHT1 bound to choline under NaCl condition, with sodium and chloride ions coordinated. | |
8ZQR | Q9GZV3 | Human high-affinity choline transporter CHT1 in apo state under NaCl condition. | |
8J74 | Q9GZV3 | Human high-affinity choline transporter CHT1 in the HC-3-bound outward-facing open conformation, dimeric state | |
8J75 | Q9GZV3 | Human high-affinity choline transporter CHT1 in the HC-3-bound outward-facing open conformation, monomeric state | |
8J77 | Q9GZV3 | Human high-affinity choline transporter CHT1 in the choline-bound inward-facing occluded conformation | |
8J76 | Q9GZV3 | Human high-affinity choline transporter CHT1 in the inward-facing apo-open conformation | |
4MJ4 | P35475 | Human iduronidase apo structure P21 form | |
8ONI | P01308 | Human insulin in complex with the analytical antibody S1 Fab | |
8ONI | 8ONI | Human insulin in complex with the analytical antibody S1 Fab | |
6VEP | P01308 | Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
6VEP | 6VEP | Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
6VEP | P06213 | Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
5J3H | 5J3H | Human insulin receptor domains L1-CR in complex with peptide S519C16 and 83-7 Fv | |
5J3H | P06213 | Human insulin receptor domains L1-CR in complex with peptide S519C16 and 83-7 Fv | |
5IUE | B3KUD8 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
5IUE | P61769 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
5IUE | 5IUE | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
5KNM | B3KUD8 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
5KNM | P61769 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
5KNM | Q8NHL6 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
5KNM | 5KNM | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
3B29 | Q16873 | Human leukotriene C4 synthase in complex with dodecyl-beta-D-selenomaltoside | |
5Q0C | O00757 | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[5-(4-methoxyphenyl)thiophen-2-yl]sulfonylurea and with fructose-2,6-diphosphate | |
3CEH | P06737 | Human liver glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE5688 | Glycogen phosphorylase (E.C.2.4.1.1) |
1L5Q | P06737 | Human liver glycogen phosphorylase a complexed with caffeine, N-Acetyl-beta-D-glucopyranosylamine, and CP-403700 | Glycogen phosphorylase, liver form (E.C.2.4.4.1) |
2ZB2 | P06737 | Human liver glycogen phosphorylase a complexed with glcose and 5-chloro-N-[4-(1,2-dihydroxyethyl)phenyl]-1H-indole-2-carboxamide | |
1L5R | P06737 | Human liver glycogen phosphorylase a complexed with riboflavin, N-Acetyl-beta-D-Glucopyranosylamine and CP-403,700 | glycogen phosphorylase, liver form (E.C.2.4.4.1) |
1L7X | P06737 | Human liver glycogen phosphorylase b complexed with caffeine, N-acetyl-beta-D-glucopyranosylamine, and CP-403,700 | Glycogen phosphorylase, liver form (E.C.2.4.1.1.) |
1L5S | P06737 | Human liver glycogen phosphorylase complexed with uric acid, N-Acetyl-beta-D-glucopyranosylamine, and CP-403,700 | Glycogen phosphorylase, liver form (E.C.2.4.4.1) |
8W2I | P17858 | Human liver phosphofructokinase-1 filament in the R-state conformation | |
8W2J | P17858 | Human liver phosphofructokinase-1 filament in the T-state conformation | |
8W2G | P17858 | Human liver phosphofructokinase-1 in the R-state conformation |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.1.1
Last updated: February 17, 2025